These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16797991

  • 1. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L.
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [Abstract] [Full Text] [Related]

  • 2. Burden of illness in Parkinson's disease.
    Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G.
    Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
    [Abstract] [Full Text] [Related]

  • 3. Direct medical costs associated with Parkinson's disease: a population-based study.
    Leibson CL, Long KH, Maraganore DM, Bower JH, Ransom JE, O'Brien PC, Rocca WA.
    Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632
    [Abstract] [Full Text] [Related]

  • 4. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E, Martínez Martin P, González M, Frades B, miembros del grupo ELEP.
    Neurologia; 2009 Nov; 24(1):15-23. PubMed ID: 19003550
    [Abstract] [Full Text] [Related]

  • 5. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P, Nordling S, Reimer J, Grabowski M, Persson U.
    Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
    [Abstract] [Full Text] [Related]

  • 6. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V, Dhoat S, Williams AJ, Dimarco A, Pal S, Forbes A, Tobías A, Martinez-Martin P, Chaudhuri KR.
    J Neurol Sci; 2006 Oct 25; 248(1-2):158-62. PubMed ID: 16780888
    [Abstract] [Full Text] [Related]

  • 7. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z, Liew D, Hollingsworth B, Wolfe R, Steg GP, Bhatt DL, Reid CM, REACH Registry Investigators.
    Clin Ther; 2010 Jan 25; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [Abstract] [Full Text] [Related]

  • 8. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
    Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, Chen SD.
    Mov Disord; 2006 Sep 25; 21(9):1439-43. PubMed ID: 16773620
    [Abstract] [Full Text] [Related]

  • 9. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
    Noyes K, Liu H, Li Y, Holloway R, Dick AW.
    Mov Disord; 2006 Mar 25; 21(3):362-72. PubMed ID: 16211621
    [Abstract] [Full Text] [Related]

  • 10. Costs of drug treatment in Parkinson's disease.
    Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH.
    Mov Disord; 1998 Mar 25; 13(2):249-54. PubMed ID: 9539337
    [Abstract] [Full Text] [Related]

  • 11. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
    Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Bötzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E.
    Parkinsonism Relat Disord; 2010 Jan 25; 16(1):51-6. PubMed ID: 19665915
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
    Davis KL, Edin HM, Allen JK.
    Mov Disord; 2010 Mar 15; 25(4):474-80. PubMed ID: 20131374
    [Abstract] [Full Text] [Related]

  • 13. Health care costs associated with posttraumatic stress disorder symptoms in women.
    Walker EA, Katon W, Russo J, Ciechanowski P, Newman E, Wagner AW.
    Arch Gen Psychiatry; 2003 Apr 15; 60(4):369-74. PubMed ID: 12695314
    [Abstract] [Full Text] [Related]

  • 14. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J, Fernandes AW, Nelson W.
    Clin Ther; 2006 Sep 15; 28(9):1462-71. PubMed ID: 17062318
    [Abstract] [Full Text] [Related]

  • 15. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R, Ramsey SD, Berry K, Brown M.
    Health Econ; 2001 Apr 15; 10(3):245-56. PubMed ID: 11288190
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing the cost of hospital care for people with diabetes in Australia.
    Clarke P, Kelman C, Colagiuri S.
    J Diabetes Complications; 2006 Apr 15; 20(6):349-55. PubMed ID: 17070437
    [Abstract] [Full Text] [Related]

  • 17. Cost of dental services provided in private general practice for an insured population in New South Wales, Australia.
    Sivaneswaran S, Taylor R, Lazarus R.
    Community Dent Health; 2000 Dec 15; 17(4):246-53. PubMed ID: 11191200
    [Abstract] [Full Text] [Related]

  • 18. Trends in resource utilization for Parkinson's disease in Germany.
    Winter Y, Balzer-Geldsetzer M, von Campenhausen S, Spottke A, Eggert K, Oertel WH, Dodel R.
    J Neurol Sci; 2010 Jul 15; 294(1-2):18-22. PubMed ID: 20493500
    [Abstract] [Full Text] [Related]

  • 19. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.
    J Drugs Dermatol; 2008 Jan 15; 7(1):41-9. PubMed ID: 18246697
    [Abstract] [Full Text] [Related]

  • 20. Population prevalence and incidence of Parkinson's disease in an Australian community.
    Mehta P, Kifley A, Wang JJ, Rochtchina E, Mitchell P, Sue CM.
    Intern Med J; 2007 Dec 15; 37(12):812-4. PubMed ID: 17561942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.